Latest Breaking News On - Company or preveceutical - Page 2 : comparemela.com

PreveCeutical Provides Update on Management Cease Trade Order

PreveCeutical Medical Inc. is providing an update with respect to the Management Cease Trade Order issued by the British Columbia Securities Commission under National Policy 12-203 - Management.

British columbiaUnited kingdomStephen van deventerPreveceutical medical incBritish columbia newsfile corpCanadian securities exchangeCompany proposed private placementCompany or preveceuticalBritish columbia securities commissionCeutical medicalManagement cease trade orderNational policyCease trade ordersAnnual filingsProposed private placementCanadian securities

PreveCeutical Announces Management Cease Trade Order

PreveCeutical Medical Inc. announces that the Company has missed the filing deadline of April 29, 2024 to file the Company s audited annual financial statements and accompanying management s.

British columbiaUnited kingdomStephen van deventerPreveceutical medical incCompany or preveceuticalCompany proposed private placementCanadian securities exchangeBritish columbia securities commissionBritish columbia newsfile corpCeutical medicalAnnual filingsManagement cease trade orderNational policyCease trade ordersProposed private placementCanadian securities

PreveCeutical Medical Inc : PreveCeutical Announces Management Cease Trade Order

PreveCeutical Medical Inc : PreveCeutical Announces Management Cease Trade Order
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomBritish columbiaStephen van deventerZwei rohstoff chancenExperte carsten storkBritish columbia securities commissionBritish columbia newsfile corpPreveceutical medical incCompany proposed private placementCompany or preveceuticalCanadian securities exchangeCeutical medicalAnnual filingsManagement cease trade orderNational policyCease trade orders

PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM

VANCOUVER, BC, Dec. 4, 2023 /PRNewswire/ - PreveCeutical Medical Inc. , is pleased to announce that it has started preparations to accelerate completion of its preclinical dual gene therapy.

British columbiaUnited statesStephen van deventerCompany or preveceuticalPreveceutical medical incGene therapy programResearch programCanadian securities exchangeCeutical medicalVan deventerChief executiveLooking statementsDual gene therapy program

PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application

/PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is proud to announce that Endosane.

British columbiaUnited statesFrankfurt am mainBaden wübergStephen van deventerFabian friedeCentral institute of mental health mannheimF markus leweke university of sydneyRegulation services providerCentre of the university sydneySanity groupEndosane pharmaceuticals gmbPreveceutical medical incEndosane pharmaceuticalsPsychotherapy researchCanadian securities exchange